TEVA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

Dollar change -0.43
Percentage change -2.51	%

Peers: JNJ ABBV AZN MRK GSK LLY PFE BMY NVS SNY

| Held by: IEFA EFA EFV IXUS PPH SPDW EIS IDEV IVLU GSIE

Index	-	P/E	-	EPS (ttm)	-0.85	Insider Own	0.01%	Shs Outstand	1.13B	Perf Week	1.21%
Market Cap	18.91B	Forward P/E	6.00	EPS next Y	2.78	Insider Trans	-86.25%	Shs Float	1.13B	Perf Month	-6.76%
Income	-961.00M	PEG	-	EPS next Q	0.69	Inst Own	56.95%	Short Float	1.60%	Perf Quarter	-11.03%
Sales	16.81B	P/S	1.12	EPS this Y	-3.50%	Inst Trans	1.70%	Short Ratio	2.71	Perf Half Y	-0.42%
Book/sh	5.35	P/B	3.12	EPS next Y	12.64%	ROA	-2.29%	Short Interest	18.09M	Perf Year	74.76%
Cash/sh	2.93	P/C	5.70	EPS next 5Y	0.24%	ROE	-14.76%	52W Range	9.35 - 19.31	Perf YTD	59.87%
Dividend Est.	-	P/FCF	6.90	EPS past 5Y	26.63%	ROI	-4.22%	52W High	-13.57%	Beta	0.81
Dividend TTM	-	Quick Ratio	0.61	Sales past 5Y	-2.68%	Gross Margin	49.97%	52W Low	78.50%	ATR (14)	0.45
Dividend Ex-Date	Nov 27, 2017	Current Ratio	0.89	EPS Y/Y TTM	57.37%	Oper. Margin	22.45%	RSI (14)	38.93	Volatility	2.22% 2.67%
Employees	37226	Debt/Eq	3.18	Sales Y/Y TTM	9.85%	Profit Margin	-5.72%	Recom	1.58	Target Price	23.00
Option/Short	Yes / Yes	LT Debt/Eq	2.75	EPS Q/Q	-647.09%	Payout	-	Rel Volume	1.75	Prev Close	17.12
Sales Surprise	4.65%	EPS Surprise	4.34%	Sales Q/Q	13.40%	Earnings	Nov 06 BMO	Avg Volume	6.68M	Price	16.69
SMA20	-4.40%	SMA50	-5.42%	SMA200	3.06%	Trades		Volume	11,713,987	Change	-2.51%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-24	Upgrade	Argus	Hold → Buy	$20
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral	$14
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight	$12 → $19
Jan-23-24	Upgrade	Jefferies	Hold → Buy	$10 → $14
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral	$8 → $12
Dec-18-23	Initiated	HSBC Securities	Buy	$13
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13
Jun-14-22	Resumed	UBS	Neutral	$10
May-17-22	Upgrade	BofA Securities	Underperform → Neutral	$9
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight	$11 → $7
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight	$11 → $13
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform	$11

Show Previous Ratings

Today 06:00PM	Teva to Present at the 7th Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-21-24 02:47AM	Teva Pharmaceutical (TEVA): The Global Leader in Affordable Medicine Under $25 (Insider Monkey)
Nov-15-24 09:09AM	Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory (Insider Monkey)
Nov-08-24 04:30PM	Teva to Present at the Jefferies London Healthcare Conference (GlobeNewswire)
09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
02:06AM	Loading…
Nov-07-24 02:06AM	Teva Pharmaceutical Industries Ltd (TEVA) Q3 2024 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Nov-06-24 04:06PM	'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe. (Investor's Business Daily) -7.14%
02:41PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
02:08PM	Teva Retreats, Sacrificing A Breakout, Despite Its Third-Quarter Beat And Raise (Investor's Business Daily)
11:30AM	Teva Pharmaceutical Industries (TEVA) Q3 2024 Earnings Call Transcript (Motley Fool)
10:08AM	Teva's Explosive Q3 Results: Pivot to Growth Strategy Shocks Investors with Record Revenue Surge (GuruFocus.com)
09:30AM	Teva Pharmaceutical Industries (TEVA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:57AM	Teva Pharmaceutical Flashes A Buy Signal On Upbeat Third-Quarter Report (Investor's Business Daily)
07:00AM	Teva Announces Strong Financial Results for the Third Quarter of 2024, led by Generics Performance and Innovative Portfolio Growth; Raises 2024 Financial Outlook including on Revenues, Adjusted EBITDA and Non-GAAP EPS (GlobeNewswire)
Nov-04-24 12:00PM	Teva Pharmaceutical Industries (TEVA) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
03:05PM	Loading…
Nov-01-24 03:05PM	Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition (GlobeNewswire)
03:00PM	Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as Results of Real-World Analyses of UZEDY (risperidone) (GlobeNewswire)
09:15AM	Countdown to Teva Pharmaceutical Industries (TEVA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
06:40AM	EC fines Teva $502m over multiple sclerosis treatment Copaxone practices (Pharmaceutical Technology)
Oct-31-24 02:49PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:26AM	Teva Fined Around $500 Million by EU Over MS Drug Competition Concerns (The Wall Street Journal)
08:46AM	EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug (Associated Press Finance)
07:30AM	Teva Statement on European Commission Decision; Company to Appeal (GlobeNewswire)
Oct-25-24 09:55AM	Wall Street Analysts Predict a 25.1% Upside in Teva Pharmaceutical Industries (TEVA): Here's What You Should Know (Zacks)
Oct-23-24 09:40AM	Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock? (Zacks)
09:40AM	Are Medical Stocks Lagging Teva Pharmaceutical Industries (TEVA) This Year? (Zacks)
Oct-22-24 06:35PM	Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory (Insider Monkey)
09:20AM	Positive Partial 12-Week Body Weight Results from Lexaria's GLP-1 Diabetes Animal Study (ACCESSWIRE)
07:00AM	Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab) (GlobeNewswire)
Oct-17-24 11:07AM	Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug (Benzinga)
12:49PM	Loading…
Oct-11-24 12:49PM	Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes (Benzinga)
Oct-10-24 05:19PM	Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations (The Wall Street Journal)
Oct-09-24 03:30PM	Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Oct-08-24 07:00AM	Teva Prolia (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA (GlobeNewswire)
Oct-07-24 09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
09:40AM	Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-04-24 06:33AM	Teva and mAbxience partner to develop biosimilar candidate for oncology (Pharmaceutical Technology)
Oct-03-24 08:30AM	Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate (GlobeNewswire)
Oct-01-24 08:29AM	Teva Announces Launch of the First and Only Generic Version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), in the U.S. (GlobeNewswire)
03:38AM	Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now? (Insider Monkey)
Sep-30-24 04:30PM	Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024 (GlobeNewswire)
01:01PM	Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ... (GuruFocus.com)
Sep-24-24 08:45AM	As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse (GlobeNewswire)
Sep-23-24 10:33AM	Teva touts safety profile of once monthly schizophrenia therapy (Pharmaceutical Technology)
01:00AM	Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia (GlobeNewswire)
Sep-21-24 04:15AM	Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia (GlobeNewswire)
04:10AM	New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY (risperidone) Extended-Release Injectable Suspension from Perseris (RBP-7000) (GlobeNewswire)
Sep-11-24 04:30PM	Teva to Present at the Bank of America 2024 Global Healthcare Conference (GlobeNewswire)
Sep-10-24 04:23PM	Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial (Reuters)
03:34PM	Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic (Pharmaceutical Technology)
Sep-06-24 01:46PM	JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability (Benzinga)
Aug-27-24 01:01PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Aug-26-24 05:00PM	Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-02-24 02:22PM	What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. (InvestorPlace)
Jul-31-24 04:13PM	Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report (Investor's Business Daily) +6.22%
02:11PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
12:00PM	Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript (Motley Fool)
10:00AM	Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
09:42AM	Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise (Investor's Business Daily)
09:40AM	Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now? (Zacks)
07:00AM	Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO ; Raises 2024 Financial Guidance (GlobeNewswire)
Jul-29-24 09:16AM	Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 01:30AM	Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease (Business Wire)
Jul-19-24 05:12AM	Teva reports positive data from Phase III paediatric migraine prevention trial (Clinical Trials Arena)
Jul-18-24 08:30AM	Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY (fremanezumab) SPACE Trial for Prevention of Episodic Migraine (Business Wire)
Jul-17-24 05:21AM	3 No-Brainer Stocks to Buy With $200 Right Now (Motley Fool)
Jul-12-24 08:22PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Jul-09-24 08:22PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +7.40%
Jul-02-24 06:00PM	Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024 (Business Wire)
01:33PM	FTC investigates Teva over contested product patents (Pharmaceutical Technology)
Jun-28-24 11:30AM	New AJOVY (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses (Business Wire)
Jun-25-24 08:00AM	Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020 (Business Wire)
Jun-24-24 04:54PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:50AM	Teva Announces Launch of Authorized Generic of Victoza (liraglutide injection 1.8mg), in the United States (Business Wire)
Jun-22-24 09:03AM	Did Teva Pharmaceutical Industries Limited (TEVA)'s Pivot to Growth Strategy Help It Get a Positive Rating from Analysts? (Insider Monkey)
Jun-21-24 01:06PM	10 Best Robinhood Stocks Under $20 (Insider Monkey)
Jun-14-24 07:15AM	7 A-Rated Biotech Stocks Worth Betting on in June (InvestorPlace)
Jun-13-24 05:35PM	Teva sues Corcept over mifepristone 'monopoly' for rare disorder (Reuters)
Jun-11-24 08:20PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Jun-04-24 04:05PM	Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-01-24 02:25PM	New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY (risperidone) Extended-Release Injectable Suspension from Invega Sustenna (paliperidone palmitate) (Business Wire)
02:20PM	Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 (Business Wire)
May-30-24 06:35AM	FDA approves Teva Pharmaceuticals AUSTEDO XR for TD and HD chorea (Pharmaceutical Technology)
May-29-24 06:38PM	Teva Announces AUSTEDO XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (2448 mg/day) (Business Wire)
May-24-24 08:11PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
May-20-24 08:25PM	Teva and Alvotech Announce SIMLANDI (adalimumab-ryvk) Injection Now Available in the U.S. (Business Wire)
May-17-24 11:00AM	Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ... (GuruFocus.com)
09:06AM	Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing (MT Newswires)
May-16-24 06:15AM	Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade (InvestorPlace)
May-15-24 09:12AM	Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing (MT Newswires)
08:15AM	Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations (Business Wire)
May-14-24 07:00AM	Israels Once-Dominant Drugmaker Is Revived by Innovation (The Wall Street Journal)
May-13-24 09:40AM	Piper Sandler Adjusts Price Target on Teva Pharmaceutical Industries to $20 From $19, Maintains Overweight Rating (MT Newswires)
09:40AM	Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock? (Zacks)
May-09-24 11:37AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:33AM	Affirm stock sinking, Good Buy or Goodbye: Market Domination (Yahoo Finance Video)
06:22AM	Teva and Medincell report positive data for TEV-749 in schizophrenia trial (Clinical Trials Arena)
May-08-24 04:29PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +12.83%
04:02PM	Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High (Investor's Business Daily)
02:10PM	Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fox Christine	EVP, Head of U.S. Commercial	Nov 20 '24	Sale	16.87	19,388	327,085	44,104	Nov 21 04:04 PM
Fox Christine	Officer	Nov 20 '24	Proposed Sale	16.87	19,388	327,085		Nov 20 11:39 AM
Daniell Richard	Exec. VP, European Commercial	Aug 12 '24	Sale	17.30	98,943	1,711,447	0	Aug 13 04:09 PM
Grant Angus	EVP, Business Development	Aug 09 '24	Sale	17.28	4,065	70,243	8,848	Aug 13 04:06 PM
Hughes Eric A	See "Remarks"	Aug 09 '24	Sale	17.38	45,060	782,972	0	Aug 13 04:02 PM
Daniell Richard	Officer	Aug 12 '24	Proposed Sale	17.30	98,943	1,711,444		Aug 12 04:09 PM
Hughes Eric A	Officer	Aug 09 '24	Proposed Sale	17.38	45,060	782,974		Aug 12 03:59 PM
Grant Angus	Officer	Aug 09 '24	Proposed Sale	17.28	4,065	70,243		Aug 09 03:59 PM
Hughes Eric A	See "Remarks"	Aug 01 '24	Sale	17.25	24,537	423,280	45,060	Aug 05 07:35 AM
Hughes Eric A	Officer	Aug 01 '24	Proposed Sale	17.25	24,537	423,281		Aug 01 04:00 PM
MIGNONE ROBERTO	Director	Jun 18 '24	Sale	17.03	519,000	8,838,570	981,000	Jun 21 04:05 PM
Weiss Amir	Chief Accounting Officer	May 15 '24	Sale	16.80	15,500	260,417	17,814	May 17 07:41 AM
Weiss Amir	Chief Accounting Officer	May 16 '24	Sale	16.65	12,635	210,377	5,179	May 17 07:41 AM
Conway Vikki L	See "Remarks"	May 13 '24	Sale	16.74	15,219	254,807	0	May 15 08:36 AM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Mar 06 '24	Sale	13.52	77,550	1,048,119	203,691	Mar 07 04:27 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '24	Sale	13.52	48,629	657,240	69,770	Mar 07 04:20 PM
Conway Vikki L	See "Remarks"	Mar 05 '24	Sale	13.52	1,427	19,286	15,219	Mar 07 04:16 PM
Sabag Mark	EVP, International Markets	Mar 05 '24	Sale	13.52	100,000	1,352,090	382,590	Mar 07 04:12 PM
Conway Vikki L	See "Remarks"	Mar 04 '24	Sale	13.37	3,532	47,234	6,617	Mar 05 04:39 PM
Francis Richard D	President and CEO	Mar 04 '24	Sale	13.34	31,061	414,270	123,295	Mar 05 04:27 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '24	Sale	13.34	95,762	1,277,207	69,770	Mar 05 04:21 PM
Hughes Eric A	See "Remarks"	Mar 04 '24	Sale	13.34	8,045	107,299	16,855	Mar 05 04:16 PM
Drape Eric	Executive VP Global Operations	Feb 28 '24	Sale	13.12	9,815	128,734	9,701	Mar 01 06:45 AM
Daniell Richard	Exec. VP, European Commercial	Feb 28 '24	Sale	13.12	20,599	270,176	69,770	Mar 01 06:43 AM
Conway Vikki L	See "Remarks"	Feb 28 '24	Sale	13.12	1,366	17,916	2,928	Mar 01 06:40 AM
Drape Eric	Executive VP Global Operations	Feb 16 '24	Sale	13.05	173,261	2,261,905	1	Feb 21 07:37 AM
Francis Richard D	President and CEO	Feb 15 '24	Sale	13.15	74,530	980,174	87,125	Feb 20 07:42 AM
Weiss Amir	Chief Accounting Officer	Feb 01 '24	Sale	12.37	31,766	392,955	10,676	Feb 05 07:49 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience